After activating EMT, cancer cells exhibit a molecular shift, characterized by decreased expression levels of epithelial markers, such as E‐cadherin, and increased expression levels of mesenchymal markers, such as β‐catenin, N‐cadherin, and fibronectin.24, 26, 27. The gene discussed is CDH1; the disease is cancer.